Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approaches

Abstract

Pancreatic cancer is a highly lethal and metastatic malignancy, mainly because it often remains undetected until advanced stages due to the limitations of current diagnostic methods, rendering currently available therapies ineffective. Therefore, it is imperative to identify useful biomarkers for early diagnosis and new therapeutic targets for pancreatic cancer. Recently, extracellular vesicles have emerged as promising biomarkers for the diagnosis and prognosis of pancreatic cancer. Given their presence in various bodily fluids, extracellular vesicles offer a non-invasive approach through liquid biopsy to detect and monitor cancer progression. In this review, we comprehensively examine the multifaceted roles of extracellular vesicles in the progression of cancer, while also exploring their potential as diagnostic, prognostic, and therapeutic biomarkers in the context of pancreatic cancer.

Keywords

Extracellular vesicles / pancreatic cancer / liquid biopsy / diagnosis biomarkers

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Partyka O,Kwaśniewska D.Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations.Cancers2023;15:3634 PMCID:PMC10377815

[3] Supadmanaba IGP,Morelli L,Lagerweij T.Organotypic-liver slide culture systems to explore the role of extracellular vesicles in pancreatic cancer metastatic behavior and guide new therapeutic approaches.Expert Opin Drug Metab Toxicol2021;17:937-46

[4] Weng J,Ding L.Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?.Semin Cancer Biol2021;74:105-20

[5] Yee NS,Schmitz KH.Frontiers in gastrointestinal oncology: advances in multi-disciplinary patient care.Biomedicines2018;6:64 PMCID:PMC6027458

[6] Irmer B,Maas L,Menck K.Extracellular vesicles in liquid biopsies as biomarkers for solid tumors.Cancers2023;15:1307 PMCID:PMC9953862

[7] Li Y,Wang Y,Liu S.Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.J Nanobiotechnology2022;20:208 PMCID:PMC9063273

[8] Zhao Z,Hsu YS,Ning B.Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application.Lab Chip2019;19:1114-40 PMCID:PMC6469512

[9] Channon LM,Xu Z.Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: key roles in the hallmarks of cancer.Biochim Biophys Acta Rev Cancer2022;1877:188728

[10] Liang Y,Zheng S.Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy.J Extracell Vesicles2021;10:e12090 PMCID:PMC8114032

[11] Maacha S,Jimenez L.Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.Mol Cancer2019;18:55 PMCID:PMC6441157

[12] Blomme A,Peulen O.Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.Oncotarget2016;7:83669-83 PMCID:PMC5347796

[13] Novizio N,Pessolano E.Annexin A1 Released in extracellular vesicles by pancreatic cancer cells activates components of the tumor microenvironment, through interaction with the formyl-peptide receptors.Cells2020;9:2719 PMCID:PMC7767312

[14] Shang D,Hu J.Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.J Cell Mol Med2020;24:588-604 PMCID:PMC6933412

[15] Li M,Wang Q.Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.Cancer Lett2020;490:20-30

[16] Cao W,He Z.Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.Aging2021;13:7120-32 PMCID:PMC7993707

[17] Costa-Silva B,Ocean AJ.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.Nat Cell Biol2015;17:816-26 PMCID:PMC5769922

[18] Chang YT,Hu CM,Tien SC.Pancreatic cancer-derived small extracellular vesical Ezrin regulates macrophage polarization and promotes metastasis.Am J Cancer Res2020;10:12-37. PMCID:PMC7017748

[19] Yin Z,Huang B.Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.J Exp Clin Cancer Res2019;38:310 PMCID:PMC6631643

[20] Armacki M,Waldenmaier M.Protein kinase D1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice.Gastroenterology2020;159:1019-35.e22

[21] Ma Q,Xiao Y,Liu T.Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.Int J Oncol2020;56:1025-33

[22] Okusaka T.Systemic chemotherapy for pancreatic cancer.Pancreas2004;28:301-4

[23] Richards KE,Fishel ML,Littlepage LE.Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.Oncogene2017;36:1770-8 PMCID:PMC5366272

[24] Essandoh K,Wang X.Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction.Biochim Biophys Acta2015;1852:2362-71 PMCID:PMC4581992

[25] Fang Y,Rong Y.Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.Exp Cell Res2019;383:111543

[26] Richards KE,Hill R.On Behalf Of The Usc Pancreas Research TeamCancer-Associated fibroblasts confer gemcitabine resistance to pancreatic cancer cells through PTEN-targeting miRNAs in exosomes.Cancers2022;14:2812 PMCID:PMC9179363

[27] Chi Y,Liu Z.Exosomal lncRNA UCA1 derived from pancreatic stellate cells promotes gemcitabine resistance in pancreatic cancer via the SOCS3/EZH2 axis.Front Oncol2021;11:671082 PMCID:PMC8640181

[28] Shen T,Shi C.Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress.FASEB J2020;34:8442-58

[29] Zhao J,Wang Z.Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer.Cancers2019;11:874 PMCID:PMC6628179

[30] Sefrioui D,Toure E.Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.Br J Cancer2017;117:1017-25 PMCID:PMC5625666

[31] Partyka K,Brand RE.Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation.Proteomics2012;12:2212-20 PMCID:PMC3711024

[32] Lennon KM,Maddox AL.Single molecule characterization of individual extracellular vesicles from pancreatic cancer.J Extracell Vesicles2019;8:1685634 PMCID:PMC6844376

[33] Melo SA,Kahlert C.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.Nature2015;523:177-82 PMCID:PMC4825698

[34] Lai X,McElyea SD,House M.A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.Cancer Lett2017;393:86-93 PMCID:PMC5386003

[35] Frampton AE,López-Jiménez E.Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.Oncotarget2018;9:19006-13 PMCID:PMC5922373

[36] Qian JY,Zhang Y,Li XQ.Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.Oncol Lett2018;16:1253-8 PMCID:PMC6019936

[37] Li H,Kwak KJ.Extracellular vesicular analysis of glypican 1 mRNA and protein for pancreatic cancer diagnosis and prognosis.Adv Sci2024;11:e2306373 PMCID:PMC10953589

[38] Liang K,Fan J.Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring.Nat Biomed Eng2017;1:0021 PMCID:PMC5543996

[39] Jin H,Wu Y.Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.Cancer Sci2018;109:2946-56 PMCID:PMC6125444

[40] Takahashi K,Kogure T.Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.Cancer Sci2020;111:98-111 PMCID:PMC6942436

[41] Chen J,Chen W.Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer.Int J Biol Markers2022;37:74-80

[42] Ying H,Yao W.Genetics and biology of pancreatic ductal adenocarcinoma.Genes Dev2016;30:355-85 PMCID:PMC4762423

[43] Yang S,Kurywchak P.Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.Cancer Biol Ther2017;18:158-65 PMCID:PMC5389423

[44] Allenson K,San Lucas FA.High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.Ann Oncol2017;28:741-7 PMCID:PMC5834026

[45] Menck K,Wachter A.Characterisation of tumour-derived microvesicles in cancer patients’ blood and correlation with clinical outcome.J Extracell Vesicles2017;6:1340745 PMCID:PMC5533131

[46] Brennan K,FitzGerald SP.A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum.Sci Rep2020;10:1039 PMCID:PMC6978318

[47] Konoshenko MY,Vlassov AV.Isolation of extracellular vesicles: general methodologies and latest trends.Biomed Res Int2018;2018:8545347 PMCID:PMC5831698

[48] Balaj L,Chen W.Heparin affinity purification of extracellular vesicles.Sci Rep2015;5:10266 PMCID:PMC4437317

[49] Welsh JA,O'Driscoll L.MISEV ConsortiumMinimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches.J Extracell Vesicles2024;13:e12404 PMCID:PMC10850029

[50] Soekmadji C,Huang Y.The future of extracellular vesicles as theranostics - an ISEV meeting report.J Extracell Vesicles2020;9:1809766 PMCID:PMC7580849

[51] Zeng Y,Jiang W.Biological features of extracellular vesicles and challenges.Front Cell Dev Biol2022;10:816698 PMCID:PMC9263222

[52] Escudé Martinez de Castilla P,Huang C.Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies.Adv Drug Deliv Rev2021;175:113801

[53] Klyachko NL,Li SM,Batrakova EV.Extracellular Vesicle-based therapeutics: preclinical and clinical investigations.Pharmaceutics2020;12:1171 PMCID:PMC7760239

[54] Herrmann IK,Fuhrmann G.Extracellular vesicles as a next-generation drug delivery platform.Nat Nanotechnol2021;16:748-59

[55] Wortzel I,Kenific CM.Exosome-mediated metastasis: communication from a distance.Dev Cell2019;49:347-60

[56] Edelmann MJ.Current understanding of extracellular vesicle homing/tropism.Zoonoses2022;2:14 PMCID:PMC9121623

[57] Nakase I,Takatani-Nakase T.Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes.Sci Rep2015;5:10300 PMCID:PMC4453128

[58] Kamerkar S,Sugimoto H.Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.Nature2017;546:498-503 PMCID:PMC5538883

[59] Alvarez-Erviti L,Yin H,Lakhal S.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.Nat Biotechnol2011;29:341-5

[60] Sterzenbach U,Low LH,Tan SS.Engineered Exosomes as vehicles for biologically active proteins.Mol Ther2017;25:1269-78 PMCID:PMC5474961

[61] Jakl V,Winkelmann M.A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor.Front Bioeng Biotechnol2023;11:1107055 PMCID:PMC9904364

[62] Papadakos SP,Pergaris A,Theocharis S.Exosomes in the treatment of pancreatic cancer: a moonshot to PDAC treatment?.Int J Mol Sci2022;23:3620 PMCID:PMC8998433

[63] El-Tanani M,Matalka II.Impact of exosome therapy on pancreatic cancer and its progression.Med Oncol2023;40:225 PMCID:PMC10322774

[64] Ariston Gabriel AN,Jiao Q.The involvement of exosomes in the diagnosis and treatment of pancreatic cancer.Mol Cancer2020;19:132 PMCID:PMC7450552

[65] Farahmand Y,Nazari A.A comprehensive survey into the role of exosomes in pancreatic cancer; from the origin of cancer to the progress and possibility of diagnosis and treatment.Pathol Res Pract2023;245:154465

[66] Catalano M.Inhibiting extracellular vesicles formation and release: a review of EV inhibitors.J Extracell Vesicles2020;9:1703244 PMCID:PMC6968539

[67] Hao Y,Zhou Z.Promotion or inhibition of extracellular vesicle release: Emerging therapeutic opportunities.J Control Release2021;340:136-48

[68] Altei WF,Dos Santos PK.Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles.Cell Commun Signal2020;18:158 PMCID:PMC7520983

[69] Tu C,Zhang H.Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells.Theranostics2021;11:2364-80 PMCID:PMC7797667

[70] Nowak M,Kołodzińska K,Choromańska A.Extracellular vesicles as drug transporters.Int J Mol Sci2023;24:10267 PMCID:PMC10299356

[71] Coccè V,Brini AT.In vitro anticancer activity of extracellular vesicles (EVs) secreted by gingival mesenchymal stromal cells primed with paclitaxel.Pharmaceutics2019;11:61 PMCID:PMC6409699

[72] De Lellis L,Di Bella MC.Exosomes as pleiotropic players in pancreatic cancer.Biomedicines2021;9:275 PMCID:PMC8002012

[73] Sharma A.Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.Nanomedicine2017;12:2137-48

[74] Mendt M,Sugimoto H.Generation and testing of clinical-grade exosomes for pancreatic cancer.JCI Insight2018;3:99263 PMCID:PMC5931131

[75] MD Anderson Cancer Center. Phase I study of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA for metastatic pancreas cancer patients harboring KrasG12D mutation. Available from: https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2018-0126.html [Last accessed on 7 May 2024]

[76] McAndrews KM,LeBleu VS.Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.J Biol Chem2021;296:100523 PMCID:PMC8042450

[77] Kabashima A,Ito S.cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.Sci Rep2022;12:10466 PMCID:PMC9247053